GLP-1 Telehealth Providers in Arizona

Yes. Arizona has some of the most telehealth-friendly regulations in the country. Providers can prescribe GLP-1 medications via video or asynchronous consultations without requiring an in-person visit.

Yes. Compounded semaglutide and tirzepatide are available through licensed compounding pharmacies in Arizona.

Arizona has broad provider availability with most major telehealth platforms operating in the state, giving you many options to compare.

Arizona Medicaid (AHCCCS) covers GLP-1 medications for type 2 diabetes management but has limited coverage for standalone weight loss. Coverage for obesity indications varies by managed care plan and is subject to prior authorization. If you have obesity and a qualifying metabolic condition, check with your specific AHCCCS health plan to see whether GLP-1s for weight management are on your formulary.

The FDA's removal of semaglutide from the drug shortage list in early 2025 ended 503B outsourcing compounding. Arizona-licensed 503A pharmacies can still compound for individual patients under specific circumstances, though options are narrower than in 2024. Ask your telehealth provider whether they source from a licensed 503A compounding pharmacy that still fills these prescriptions.

No referral is needed for a telehealth GLP-1 evaluation in Arizona. AHCCCS and private insurance both require prior authorization for brand-name GLP-1 medications. Cash-pay telehealth programs have no referral requirement. Most async platforms issue a prescription decision within 24–72 hours.

Arizona residents can start through an async telehealth platform with a prescription decision in 24–72 hours. Video consultations are typically available within a few days. Medication ships to your Arizona address after prescribing — delivery takes 3–7 days from most telehealth-affiliated pharmacies.